Literature DB >> 15517985

Crystal structure of the pig pancreatic alpha-amylase complexed with rho-nitrophenyl-alpha-D-maltoside-flexibility in the active site.

Huanyu Zhuo1, Françoise Payan, Minxie Qian.   

Abstract

The X-ray structure analysis of a crystal of pig pancreatic alpha-amylase soaked with a rho-nitrophenyl-alpha-D-maltoside (pNPG2) substrate showed a pattern of electron density corresponding to the binding of a rho-nitrophenol unit at subsite -2 of the active site. Binding of the product to subsite -2 after hydrolysis of the pNPG2 molecules, may explain the low catalytic efficiency of the hydrolysis of pNPG2 by PPA. Except a small movement of the segment from residues 304-305 the typical conformational changes of the "flexible loop" (303-309), that constitutes the surface edge of the substrate binding cleft, were not observed in the present complex structure. This result supports the hypothesis that significant movement of the loop may depend on aglycone site being filled (Payan and Qian, J. Protein Chen. 22: 275, 2003). Structural analyses have shown that pancreatic alpha-amylases undergo an induced conformational change of the catalytic residue Asp300 upon substrate binding; in the present complex the catalytic residue is observed in its unliganded orientation. The results suggest that the induced reorientation is likely due to the presence of a sugar unit at subsite -1 and not linked to the closure of the flexible surface loop. The crystal structure was refined at 2.4 A resolution to an R factor of 17.55% (Rfree factor of 23.32%).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517985     DOI: 10.1023/b:jopc.0000039552.94529.95

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  21 in total

1.  X-ray structures along the reaction pathway of cyclodextrin glycosyltransferase elucidate catalysis in the alpha-amylase family.

Authors:  J C Uitdehaag; R Mosi; K H Kalk; B A van der Veen; L Dijkhuizen; S G Withers; B W Dijkstra
Journal:  Nat Struct Biol       Date:  1999-05

2.  Crystal structures of human pancreatic alpha-amylase in complex with carbohydrate and proteinaceous inhibitors.

Authors:  V Nahoum; G Roux; V Anton; P Rougé; A Puigserver; H Bischoff; B Henrissat; F Payan
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

3.  Structure of a pancreatic alpha-amylase bound to a substrate analogue at 2.03 A resolution.

Authors:  M Qian; S Spinelli; H Driguez; F Payan
Journal:  Protein Sci       Date:  1997-11       Impact factor: 6.725

4.  Mechanistic analyses of catalysis in human pancreatic alpha-amylase: detailed kinetic and structural studies of mutants of three conserved carboxylic acids.

Authors:  Edwin H Rydberg; Chunmin Li; Robert Maurus; Christopher M Overall; Gary D Brayer; Stephen G Withers
Journal:  Biochemistry       Date:  2002-04-02       Impact factor: 3.162

5.  The action pattern of porcine pancreatic alpha-amylase in relationship to the substrate binding site of the enzyme.

Authors:  J F Robyt; D French
Journal:  J Biol Chem       Date:  1970-08-10       Impact factor: 5.157

Review 6.  Mechanisms of enzymatic glycoside hydrolysis.

Authors:  J D McCarter; S G Withers
Journal:  Curr Opin Struct Biol       Date:  1994-12       Impact factor: 6.809

7.  Refined molecular structure of pig pancreatic alpha-amylase at 2.1 A resolution.

Authors:  S B Larson; A Greenwood; D Cascio; J Day; A McPherson
Journal:  J Mol Biol       Date:  1994-02-04       Impact factor: 5.469

8.  Subsite mapping of the human pancreatic alpha-amylase active site through structural, kinetic, and mutagenesis techniques.

Authors:  G D Brayer; G Sidhu; R Maurus; E H Rydberg; C Braun; Y Wang; N T Nguyen; C M Overall; S G Withers
Journal:  Biochemistry       Date:  2000-04-25       Impact factor: 3.162

9.  Crystal structure of the pig pancreatic alpha-amylase complexed with malto-oligosaccharides.

Authors:  Françoise Payan; Minxie Qian
Journal:  J Protein Chem       Date:  2003-04

10.  Structure of human salivary alpha-amylase at 1.6 A resolution: implications for its role in the oral cavity.

Authors:  N Ramasubbu; V Paloth; Y Luo; G D Brayer; M J Levine
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1996-05-01
View more
  5 in total

1.  A Multidirectional Perspective for Novel Functional Products: In vitro Pharmacological Activities and In silico Studies on Ononis natrix subsp. hispanica.

Authors:  Serife Yerlikaya; Gokhan Zengin; Adriano Mollica; Mehmet C Baloglu; Yasemin Celik Altunoglu; Abdurrahman Aktumsek
Journal:  Front Pharmacol       Date:  2017-09-01       Impact factor: 5.810

2.  Traditionally Used Lathyrus Species: Phytochemical Composition, Antioxidant Activity, Enzyme Inhibitory Properties, Cytotoxic Effects, and in silico Studies of L. czeczottianus and L. nissolia.

Authors:  Eulogio J Llorent-Martínez; Gokhan Zengin; María L Fernández-de Córdova; Onur Bender; Arzu Atalay; Ramazan Ceylan; Adriano Mollica; Andrei Mocan; Sengul Uysal; Gokalp O Guler; Abdurrahman Aktumsek
Journal:  Front Pharmacol       Date:  2017-02-27       Impact factor: 5.810

Review 3.  Polyphenolic Compounds and Digestive Enzymes: In Vitro Non-Covalent Interactions.

Authors:  Alejandra I Martinez-Gonzalez; Ángel G Díaz-Sánchez; Laura A de la Rosa; Claudia L Vargas-Requena; Ismael Bustos-Jaimes; And Emilio Alvarez-Parrilla
Journal:  Molecules       Date:  2017-04-22       Impact factor: 4.411

4.  Functional constituents of wild and cultivated Goji (L. barbarum L.) leaves: phytochemical characterization, biological profile, and computational studies.

Authors:  Andrei Mocan; Gökhan Zengin; Mario Simirgiotis; Michaela Schafberg; Adriano Mollica; Dan C Vodnar; Gianina Crişan; Sascha Rohn
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

5.  Integration of in vitro and in silico perspectives to explain chemical characterization, biological potential and anticancer effects of Hypericum salsugineum: A pharmacologically active source for functional drug formulations.

Authors:  Onur Bender; Eulogio J Llorent-Martínez; Gokhan Zengin; Adriano Mollica; Ramazan Ceylan; Lucia Molina-García; Maria Luisa Fernández-de Córdova; Arzu Atalay
Journal:  PLoS One       Date:  2018-06-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.